Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine

20 Jan 2021

Abstract excerpt

), a live-attenuated recombinant vesicular stomatitis virus vector expressing the glycoprotein G of Zaire Ebolavirus, is the first vaccine approved for prevention of EVD. Both innate and adaptive responses are deemed to be involved in vaccine-induced protection, yet the mechanisms are not fully elucidated. A global transcriptomic approach was used to profile the blood host-response in 51 healthy volunteers...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Viral Infections and Outbreaks Research
Share to Viral Infections and Vectors

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33498214
DOI: 10.3390/vaccines9020067

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human Transcriptomic Response to the VSV-Vectored Ebola VaccinePMID 33498214Read ↗

Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GPSemantic proximity Read ↗

Transcriptome Analysis of Circulating Immune Cell Subsets Highlight the Role of Monocytes in Zaire Ebola Virus Makona PathogenesisSemantic proximity Read ↗

A curated transcriptome dataset collection to investigate the blood transcriptional response to viral respiratory tract infection and vaccination.Semantic proximity Read ↗

Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variantsSemantic proximity Read ↗

Long Non-Coding RNAs in Response to Ebola Virus Vaccine-Induced ImmunitySemantic proximity Read ↗

Integrative systems vaccinology identification of shared gene signatures between natural dengue infection and vaccination trialsSemantic proximity Read ↗

Cellular and Humoral Immunity to Ebola Zaire Glycoprotein and Viral Vector Proteins Following Immunization with Recombinant Vesicular Stomatitis Virus-Based Ebola Vaccine (rVSVΔG-EBOV-GP)Semantic proximity Read ↗

Differential gene expression in peripheral blood mononuclear cells from children immunized with inactivated influenza vaccineSemantic proximity Read ↗

Comparative Transcriptomics in Ebola Makona-Infected Ferrets, Nonhuman Primates, and HumansSemantic proximity Read ↗

Comparison of Transcriptomic Platforms for Analysis of Whole Blood from Ebola-Infected Cynomolgus MacaquesSemantic proximity Read ↗

Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virusSemantic proximity Read ↗

Long-lasting severe immune dysfunction in Ebola virus disease survivorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.